Boston Scientific Corporation is an American medical device manufacturer. The company offers solutions for the following medical specialties: electrophysiology, gastroenterology, vascular surgery, gynecology, interventional cardiology, interventional radiology, female pelvic medicine, neurological surgery, orthopedic surgery, pulmology, pain medicine, structural heart, urology.
According to Boston Scientific's latest financial reports the company has $0.72 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $0.41 B | -52.14% |
2023-12-31 | $0.86 B | -6.79% |
2022-12-31 | $0.92 B | -51.79% |
2021-12-31 | $1.92 B | 11.01% |
2020-12-31 | $1.73 B | 699.08% |
2019-12-31 | $0.21 B | 48.63% |
2018-12-31 | $0.14 B | -22.34% |
2017-12-31 | $0.18 B | -4.08% |
2016-12-31 | $0.19 B | -38.56% |
2015-12-31 | $0.31 B | -45.66% |
2014-12-31 | $0.58 B | 170.51% |
2013-12-31 | $0.21 B | 4.83% |
2012-12-31 | $0.20 B | -22.47% |
2011-12-31 | $0.26 B | 25.35% |
2010-12-31 | $0.21 B | -75.35% |
2009-12-31 | $0.86 B | -47.35% |
2008-12-31 | $1.64 B | 13.02% |
2007-12-31 | $1.45 B | -12.95% |
2006-12-31 | $1.66 B | 96.7% |
2005-12-31 | $0.84 B | -48.29% |
2004-12-31 | $1.64 B | 144.41% |
2003-12-31 | $0.67 B | 142.24% |
2002-12-31 | $0.27 B | 49.73% |
2001-12-31 | $0.18 B | 208.33% |
2000-12-31 | $60 M | -23.08% |
1999-12-31 | $78 M | 4% |
1998-12-31 | $75 M | 29.31% |
1997-12-31 | $58 M | -19.67% |
1996-12-31 | $72.2 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Edwards Lifesciences EW | $3.89 B | 437.72% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $2.40 B | 232.28% | ๐บ๐ธ USA |
![]() Merit Medical MMSI | $0.39 B | -45.44% | ๐บ๐ธ USA |
![]() Medtronic MDT | $8.96 B | 1,136.55% | ๐ฎ๐ช Ireland |
![]() Teleflex TFX | $0.28 B | -60.81% | ๐บ๐ธ USA |
![]() AngioDynamics ANGO | $44.76 M | -93.83% | ๐บ๐ธ USA |
![]() CONMED CNMD | $35.48 M | -95.11% | ๐บ๐ธ USA |